Mankind Pharma Limited — Capital/Financing Update 2024

Sep 30, 2024

==> picture [559 x 53] intentionally omitted <==

==> picture [559 x 55] intentionally omitted <==

Date: September 30, 2024

BSE Limited P J Towers, Dalal Street, Mumbai – 400 001

Script Code: 543904

National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051

Symbol: MANKIND

Dear Sir/ Madam,

Subject: Final update on transfer Over the Counter Business Undertaking of the Company as a going concern on a slump sale basis to Mankind Consumer Products Private Limited, a wholly owned subsidiary

In compliance with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to our communication dated April 2, 2024 and September 3, 2024, please note that the Company has completed the transfer of Over the Counter (OTC) Business Undertaking (defined in the BTA) of the Company as a going concern on a slump sale basis to Mankind Consumer Products Private Limited (MCPPL), a wholly owned subsidiary of the Company on September 30, 2024.

This is for your information and records.

Thanking You,

Yours Faithfully,

For Mankind Pharma Limited

PRADEEP Digitally signed by PRADEEP CHUGH CHUGH Date: 2024.09.30 18:11:04 +05'30' Pradeep Chugh Company Secretary and Compliance Officer

==> picture [557 x 60] intentionally omitted <==